Evaluation of mean platelet volume and platelet count in patients with schizophrenia

Introduction: Compared to the general population, cardiovascular diseases are more common in schizophrenia patients and the mortality rate is higher than the general population. One of the explanations for increased cardiovascular events in patients with schizophrenia is the increase in platelet act...

Full description

Bibliographic Details
Main Authors: Ibrahim Eren, Yusuf Cokunlu, Bilge Cetin Ilhan, Memduha Aydin, Tuba Serife Elmas
Format: Article
Language:English
Published: SERNEV 2018-08-01
Series:Family Practice and Palliative Care
Subjects:
Online Access:https://dergipark.org.tr/en/download/article-file/541854
_version_ 1797244634808713216
author Ibrahim Eren
Yusuf Cokunlu
Bilge Cetin Ilhan
Memduha Aydin
Tuba Serife Elmas
author_facet Ibrahim Eren
Yusuf Cokunlu
Bilge Cetin Ilhan
Memduha Aydin
Tuba Serife Elmas
author_sort Ibrahim Eren
collection DOAJ
description Introduction: Compared to the general population, cardiovascular diseases are more common in schizophrenia patients and the mortality rate is higher than the general population. One of the explanations for increased cardiovascular events in patients with schizophrenia is the increase in platelet activity. Platelets are essential for progression of atherosclerotic lesions, plaque destabilization, and thrombus formation. Mean platelet volume (MPV) is a measure of platelet size and a good marker of platelet function and activation, which increases in cardiovascular diseases. MPV is routinely reported during complete blood count analysis. The aim of the present study was to evaluate MPV values of patients with schizophrenia. Methods: In this retrospective study, hospital-records of the patients who were consecutively admitted to psychiatry inpatient clinic between January 2015 and January 2017 with the diagnosis of schizophrenia were reviewed. Healthy subjects with no personal history of psychiatric disorder were included as a control group.  Results: A total of 100 (59 female, 41 male) schizophrenic patients who had been consecutively admitted to the psychiatry inpatient clinic and 37 (20 female, 17 male) healthy controls were included in this retrospective study. There were no significant differences between the patient group and control group in the terms of age (mean age patient group vs control group: 37.72 vs 35.03, p=0.081) and sex (p=0.603). Body mass index (BMI) was found to be significantly different between groups, higher in the patient group (p=0.001). The MPV was found to be significantly higher in patient group compared with the control group (MPV, patient group vs control group: 10.34 fL vs 9.97 fL, p=0.041). Platelet count (PC) was significantly lower in the patient group (PC, patient group vs control group: 234.36 vs 267.38, p=0.008) There was no correlation between MPV and BMI (p=0.354, r=0.10), and duration of illness (p=0.530, r=0.06).  Conclusions: As a result, increased MPV and decreased PC were found in a group of schizophrenic patient in this study. Since increased MPV and decreased PC are evaluated as risk factors for cardiovascular diseases in the general population, they can also be considered as a predictor of risk factors for cardiovascular diseases that are more frequently encountered in schizophrenia.
first_indexed 2024-03-08T18:58:59Z
format Article
id doaj.art-7a43c5be222b420a80615585bbd60e9a
institution Directory Open Access Journal
issn 2459-1505
language English
last_indexed 2024-04-24T19:14:08Z
publishDate 2018-08-01
publisher SERNEV
record_format Article
series Family Practice and Palliative Care
spelling doaj.art-7a43c5be222b420a80615585bbd60e9a2024-03-26T08:15:56ZengSERNEVFamily Practice and Palliative Care2459-15052018-08-013210210710.22391/fppc.401101544Evaluation of mean platelet volume and platelet count in patients with schizophreniaIbrahim Eren0Yusuf Cokunlu1Bilge Cetin Ilhan2Memduha Aydin3Tuba Serife Elmas4Konya Training and Research Hospital, Department of Psychiatry, KonyaKonya Training and Research Hospital, Department of Psychiatry, KonyaKonya Training and Research Hospital, Department of Psychiatry, KonyaSelcuk University, Faculty of Medicine, Department of Psychiatry, KonyaKonya Training and Research Hospital, Department of Psychiatry, KonyaIntroduction: Compared to the general population, cardiovascular diseases are more common in schizophrenia patients and the mortality rate is higher than the general population. One of the explanations for increased cardiovascular events in patients with schizophrenia is the increase in platelet activity. Platelets are essential for progression of atherosclerotic lesions, plaque destabilization, and thrombus formation. Mean platelet volume (MPV) is a measure of platelet size and a good marker of platelet function and activation, which increases in cardiovascular diseases. MPV is routinely reported during complete blood count analysis. The aim of the present study was to evaluate MPV values of patients with schizophrenia. Methods: In this retrospective study, hospital-records of the patients who were consecutively admitted to psychiatry inpatient clinic between January 2015 and January 2017 with the diagnosis of schizophrenia were reviewed. Healthy subjects with no personal history of psychiatric disorder were included as a control group.  Results: A total of 100 (59 female, 41 male) schizophrenic patients who had been consecutively admitted to the psychiatry inpatient clinic and 37 (20 female, 17 male) healthy controls were included in this retrospective study. There were no significant differences between the patient group and control group in the terms of age (mean age patient group vs control group: 37.72 vs 35.03, p=0.081) and sex (p=0.603). Body mass index (BMI) was found to be significantly different between groups, higher in the patient group (p=0.001). The MPV was found to be significantly higher in patient group compared with the control group (MPV, patient group vs control group: 10.34 fL vs 9.97 fL, p=0.041). Platelet count (PC) was significantly lower in the patient group (PC, patient group vs control group: 234.36 vs 267.38, p=0.008) There was no correlation between MPV and BMI (p=0.354, r=0.10), and duration of illness (p=0.530, r=0.06).  Conclusions: As a result, increased MPV and decreased PC were found in a group of schizophrenic patient in this study. Since increased MPV and decreased PC are evaluated as risk factors for cardiovascular diseases in the general population, they can also be considered as a predictor of risk factors for cardiovascular diseases that are more frequently encountered in schizophrenia.https://dergipark.org.tr/en/download/article-file/541854kardiyovasküler hastalıklarortalama trombosit hacmişizofrenicardiovascular diseasesmean platelet volumeschizophrenia
spellingShingle Ibrahim Eren
Yusuf Cokunlu
Bilge Cetin Ilhan
Memduha Aydin
Tuba Serife Elmas
Evaluation of mean platelet volume and platelet count in patients with schizophrenia
Family Practice and Palliative Care
kardiyovasküler hastalıklar
ortalama trombosit hacmi
şizofreni
cardiovascular diseases
mean platelet volume
schizophrenia
title Evaluation of mean platelet volume and platelet count in patients with schizophrenia
title_full Evaluation of mean platelet volume and platelet count in patients with schizophrenia
title_fullStr Evaluation of mean platelet volume and platelet count in patients with schizophrenia
title_full_unstemmed Evaluation of mean platelet volume and platelet count in patients with schizophrenia
title_short Evaluation of mean platelet volume and platelet count in patients with schizophrenia
title_sort evaluation of mean platelet volume and platelet count in patients with schizophrenia
topic kardiyovasküler hastalıklar
ortalama trombosit hacmi
şizofreni
cardiovascular diseases
mean platelet volume
schizophrenia
url https://dergipark.org.tr/en/download/article-file/541854
work_keys_str_mv AT ibrahimeren evaluationofmeanplateletvolumeandplateletcountinpatientswithschizophrenia
AT yusufcokunlu evaluationofmeanplateletvolumeandplateletcountinpatientswithschizophrenia
AT bilgecetinilhan evaluationofmeanplateletvolumeandplateletcountinpatientswithschizophrenia
AT memduhaaydin evaluationofmeanplateletvolumeandplateletcountinpatientswithschizophrenia
AT tubaserifeelmas evaluationofmeanplateletvolumeandplateletcountinpatientswithschizophrenia